# Keyin Biotechnology

Keyin Biology develops innovative AI drugs. It rapidly built a first-principles de novo drug design platform that systematically explores chemical space and improves virtual discovery for new targets. By efficiently integrating upstream and downstream partners and coordinating internal and external R&D, it improves the DMTA cycle and reduces experimentation costs and timelines.

Keyin Biology develops innovative AI drugs. It rapidly built a first-principles de novo drug design platform that systematically explores chemical space and improves virtual discovery for new targets. By efficiently integrating upstream and downstream partners and coordinating internal and external R&D, it improves the DMTA cycle and reduces experimentation costs and timelines.

Canonical: https://uniquebase.ai/products/keyinshengwu
Stable identifier: UB-D356
Snapshot captured: 2026-10-15T14:23:27.067Z
English updated: 2026-10-15T22:47:27.842Z

## Connected profiles

- [Keyin Biotechnology](/companies/keyinshengwu)

## Sources

- No source links are available for this profile.